Candel Therapeutics Inc (CADL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,177 | -37,939 | -18,794 | -36,124 | -17,680 |
| Depreciation Amortization | 990 | 960 | 778 | 232 | 91 |
| Accounts payable and accrued liabilities | -185 | 45 | -1,213 | 669 | 289 |
| Other Working Capital | 346 | -525 | 71 | -876 | 1,774 |
| Other Operating Activity | 27,003 | 3,215 | -12,261 | 13,881 | 6,455 |
| Operating Cash Flow | $-27,023 | $-34,244 | $-31,419 | $-22,218 | $-9,071 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 39,931 |
| PPE Investments | -16 | -280 | -1,297 | -1,835 | -1,476 |
| Investing Cash Flow | $-16 | $-280 | $-1,297 | $-1,835 | $38,455 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 460 |
| Debt Issued | N/A | N/A | 19,910 | N/A | N/A |
| Debt Repayment | -9,167 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 103,447 | N/A | 64 | 71,800 | 30 |
| Other Financing Activity | 0 | -121 | 0 | 0 | 0 |
| Financing Cash Flow | $94,280 | $-121 | $19,974 | $71,800 | $490 |
| Beginning Cash Position | 35,679 | 70,324 | 83,066 | 35,319 | 5,445 |
| End Cash Position | 102,920 | 35,679 | 70,324 | 83,066 | 35,319 |
| Net Cash Flow | $67,241 | $-34,645 | $-12,742 | $47,747 | $29,874 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,023 | -34,244 | -31,419 | -22,218 | -9,071 |
| Capital Expenditure | -16 | -457 | -1,297 | -1,835 | -1,476 |
| Free Cash Flow | -27,039 | -34,701 | -32,716 | -24,053 | -10,547 |